MedTrace Logo

Brief Behavioural Economic Intervention for Smoking Cessation

NCT06451081 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1017

Last updated 2024-07-19

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effectiveness of brief behavioural economic intervention in promoting smoking cessation among smokers in the community.

Conditions

  • Tobacco Smoking

Interventions

BEHAVIORAL

Brief cessation advice

Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model: A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again

BEHAVIORAL

Opt-out active referral

Participants will be automatically referred to a smoking cessation service upon joining the trial, unless they choose to opt out. Contacts of participants will be delivered to a service provider of their choice or based on their living district and preferred treatment modality

BEHAVIORAL

Behavioral economic mobile messaging

Participants will receive behavioural economics-informed messages via mobile instant messaging for 3 months

BEHAVIORAL

Opt-in active referral

Participants will be offered a referral to a smoking cessation service. Contacts of participants who opt-in will be delivered to a service provider of their choice

Sponsors & Collaborators

  • Hong Kong Council on Smoking and Health

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Tzu Tsun Luk, PhD, RN · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-15
Primary Completion
2025-04-30
Completion
2025-05-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06451081 on ClinicalTrials.gov